Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Medpace stock down 18% after CEO talks of ‘permanent or increasing margin headwind’

February 27, 2018 By Chris Newmarker

MedpaceThe stock of clinical contract research organization Medpace (Nasdaq: MEDP) took a hit today after the company’s CEO Dr. August Troendle told analysts that the company is facing a “relatively permanent or increasing margin headwind in the next few years.”

Medpace’s stock was down $7.02 per share, or nearly 18%, to $32.02 by the close of trading. Troendle in a conference call with analysts this morning said he expected the company’s EBITDA margin — its earnings before interest, taxes, depreciation and amortization as a percentage of total revenue — to be 25% in 2018, down from 28% in 2017.

Troendle blamed foreign exchange rates, bonus accrual, the need to expand and enhance infrastructure in several locations through 2020, increased business development activities, and an above usual uptick in labor costs. He described the foreign exchange rates as a wild card but said he believed the other costs would continue to hold down the company’s margin.

The news came even as Cincinnati-based Medpace finished what Troendle described as a “strong finish to a challenging year” that beat analysts’ expectations.

For the quarter ended Dec. 31, Medpace earned $11.3 million, or 30 cents per share, off $112.7 million in revenue, versus a loss of $21,000 off $108.2 million in revenue for the same period a year before.

Adjusted net income for the fourth quarter was 39 cents per share.

The results beat the expectations of analysts, who on average expected earnings of 38 cents per share off $97.7 million in revenue for the quarter, according to Yahoo! Finance.

For all of 2017, Medpace saw profits of $39.1 million, or 98 cents per share, off $436.2 million in revenue, up from profits of $13.4 million, or 37 cents per share,  off $421.6 million in revenue for 2016.

Adjusted net income for 2017 was $1.52 per share.

The full-year results also beat the Street, where analysts on average expected earnings of $1.50 per share off $384.8 million in revenue, according to Yahoo! Finance.

Medpace for 2018 is projecting net service revenue in the range of $412 million to $428 million, representing growth of 6.6% to 10.7% over net service revenue of $386.5 million in 2017. Adjusted net income is expected to be $1.82 to $1.93 per share.

Related Articles Read More >

DermaSensor skin cancer MedTech Innovator DeviceTalks Boston
DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
Steris
Steris rises on Street-beating Q4, sets fiscal 2023 guidance
A portrait of AcuityMD co-founder and CEO Michael Monovoukas
Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
Rockley Photonics
Rockley Photonics announces $81.5M private placement

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech